Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Kidney Diseases × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 6 Multiple Myeloma 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Urologic Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Kidney Neoplasms 1 Kidney Diseases 1 Gliosarcoma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

cabozantinib 1 VMBP protocol 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300140 2023-10-30

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Aravive, Inc.

Phase 1/2 Terminated

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡